NCT04556786 is a NA clinical trial of Transitions of care in Chronic Disease, sponsored by Auburn University.

Who is sponsoring NCT04556786?

NCT04556786 is sponsored by Auburn University.

What drugs are being tested in NCT04556786?

Interventions in NCT04556786: Transitions of care.

What condition does NCT04556786 study?

NCT04556786 studies Chronic Disease.

Is NCT04556786 still recruiting?

NCT04556786 is currently completed. Last updated 21 September 2020.

Last reviewed 2020-09-21 · How we verify

NCT04556786

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pharmacist-led Transitions of Care Program

Completed NA Last updated 21 September 2020

What this trial tests

NA trial testing Transitions of care in Chronic Disease in 88 participants. Completed in 16 July 2019.

Timeline

2 October 2018

Primary endpoint
16 July 2019

16 July 2019

Quick facts

Lead sponsor	Auburn University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	88
Start date	2 October 2018
Primary completion	16 July 2019
Estimated completion	16 July 2019
Sites	1 location across United States

Drugs / interventions tested

Transitions of care

Conditions studied

Chronic Disease — all drugs for Chronic Disease →

Sponsor

Auburn University

Who can join

18 and older, any sex, with Chronic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was to show the value of pharmacists in providing transitions of care to and improving health outcomes of uninsured populations. It also aimed to demonstrate the feasibility of implementing a transitions of care program in an indigent care clinic with limited resources. We hypothesized that a pharmacist-led transitions of care program will reduce 30-day hospital readmission rates among the uninsured discharged from a community hospital.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Medication review in hospitalised patients to reduce morbidity and mortality.
Bülow C, Clausen SS, Lundh A, Christensen M. · · 2023 · cited 37× · PMID 36688482 · DOI 10.1002/14651858.cd008986.pub4
Can the LACE index help identify uninsured patients at risk of loss to follow-up during a pharmacist-led transitions of care program?
Chou C, McDaniel CC, Harris SM, Lai TC, et al · · 2022 · PMID 34802945 · DOI 10.1016/j.japh.2021.11.001

Verify or expand the search:

Other recruiting trials for Chronic Disease

Currently open trials in the same condition.

NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07375550 — Determinants of Medication Non-Adherence Among Patients With Chronic Diseases in Egyptian Community Pharmacies · recruiting
NCT07120464 — Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations · recruiting

Other Auburn University trials

Trials by the same sponsor.

NCT05621538 — A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder · NA · recruiting
NCT06274112 — Using TMS to Understand Neural Processes of Social Motivation · NA · recruiting
NCT07489105 — Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function · NA · recruiting
NCT06565637 — Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders · Phase 1 · recruiting
NCT06531863 — Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04556786 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Auburn University
Last refreshed: 21 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04556786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing